Translation of "Knochenabbau" in English

Osteoporosis is more common in women after the menopause, when the levels of the female hormone oestrogen fall: oestrogen slows down bone breakdown and makes the bones less likely to fracture.

Only a bacteria-proof connection prevents bone resorption – and stabilizes the soft tissue.

Aesthetic dental treatment can be necessary to compensate for bone-loss in the lower jaw.

Osteoporosis is one of the most common bone diseases and is characterised by bone loss.

Bisphosphonates are a group of medications which slow down bone loss.

Biophosphonates are a group of medications which slow down bone loss.

A lack of exercise can cause age-related bone loss – osteoporosis –.

These if not cured lead to bone destruction and tooth loss.

This bone loss can lead to fragile and instable bones that break more easily.

Bone resorption by osteoclasts in turn involves cleavage of cross-linked collagen.

A bone degradation due to a lack of mechanical stimulation is thereby countered.

This may in turn have an impact on bone degradation at the post part.

Implants prevent progressing bone resorption in toothless jaw regions.

Further bone loss in the jaw is avoided.

After menopause, the loss is doubled in women.

It alters the cycle of bone formation and breakdown in the body.

Bones loss causes the bones to become porous, unstable and susceptible to fractures.

Osteoporosis is one of the most common bone diseases and is characterised by bone loss.

At this point the balance between bone loss and bone formation stabilises.

At the same time, vitamin D inhibits the formation of the parathyroid hormone, which promotes bone degradation.

Since they also prevent bone degradation, they can be used in the treatment of osteoporosis.

In osteoporosis, the equilibrium is disturbed such that bone degradation occurs.